osilodrostat
Selected indexed studies
- Osilodrostat. (, 2006) [PMID:33355740]
- Randomized Trial of Osilodrostat for the Treatment of Cushing Disease. (J Clin Endocrinol Metab, 2022) [PMID:35325149]
- Osilodrostat: Short Chapter. (, 2012) [PMID:39110831]
_Worker-drafted node — pending editorial review._
Connections
osilodrostat is a side effect of
Sources
- Osilodrostat (Isturisa) for Cushing's disease. (2021) pubmed
- Osilodrostat. (2006) pubmed
- Randomized Trial of Osilodrostat for the Treatment of Cushing Disease. (2022) pubmed
- Osilodrostat: Short Chapter. (2012) pubmed
- Osilodrostat: First Approval. (2020) pubmed
- Osilodrostat for Cushing Disease and Its Role in Pediatrics. (2023) pubmed
- Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France. (2023) pubmed
- Osilodrostat for the treatment of Cushing's disease. (2021) pubmed
- Osilodrostat for Cushing syndrome. (2025) pubmed
- Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations. (2025) pubmed